The objective of this study is to demonstrate the clinical validity, analytical validity and safety of ViewMind Atlas as an adjunctive tool to be used by healthcare professionals (HCP) evaluating cognitive impairment in adults aged 45 to 95 years old.
Who can participate
Age range45 Years – 95 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
* Male or female, aged between 45 and 95 years.
* Cohort 1: Presence of cognitive complaints and objectively measured cognitive impairment of an MMSE of \> 26, such as memory loss or other cognitive difficulties (60% of the overall study population). These complaints can be self-reported or noted by a close family member. Diagnosis of MCI by PI or delegated qualified provider on the study team.
* Cohort 2: Absence of cognitive complaints and absence of objectively measured cognitive impairment as determined by MMSE \> 26 and neuropsychological tests. Diagnosis of CN by PI or delegated qualified provider on the study team (40% of the overall study population).
* Willing to sign written informed consent and ability to comply with study requirements.
* Have adequate vision and hearing, with or without corrective devices, to ensure accurate self-reporting and comprehension of study materials.
Exclusion Criteria:
An individual who meets any of the following criteria will be excluded from participation in this study:
* Participants with dementia, defined here as an MMSE of \< 25 and diagnosis of cognitive decline that is not MCI but more severe in nature by the PI or delegated qualified provider on the study team.
* Advanced, severe progressive or unstable disease that may interfere with the safety, tolerability and study assessments, or put the part…
What they're measuring
1
Accuracy of ViewMind Atlasâ„¢ in Identifying Cognitive Impairment